Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

BACKGROUND: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. METHODS: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patien...

詳細記述

保存先:
書誌詳細
出版年:EClinicalMedicine
主要な著者: Duarte, Mariano, Pelorosso, Facundo, Nicolosi, Liliana N., Victoria Salgado, M., Vetulli, Héctor, Aquieri, Analía, Azzato, Francisco, Castro, Marcela, Coyle, Javier, Davolos, Ignacio, Criado, Ignacio Fernandez, Gregori, Rosana, Mastrodonato, Pedro, Rubio, María C., Sarquis, Sergio, Wahlmann, Fernando, Rothlin, Rodolfo P.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2021
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8225700/
https://ncbi.nlm.nih.gov/pubmed/34189447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100962
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料